Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heritable variation of ERBB2 and breast cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2009

Breyer Joan P, Sanders Melinda E, Airey David C, Cai Qiuyin, Yaspan Brian L, Schuyler Peggy A, Dai Qi, Boulos Fouad, Olivares Maria G, Bradley Kevin M, Gao Yu-Tang, Page David L, Dupont William D, Zheng Wei, Smith Jeffrey R

Abstract excerpt

Amplification of the epithelial growth factor receptor gene ERBB2 (HER2, NEU) in breast cancer is associated with a poor clinical prognosis. In mammary gland development, this receptor plays a role in ductal and lobuloalveolar differentiation. We conducted a systematic investigation of the role o...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Carcinoma, Lobular

Share to Linkage Disequilibrium

Share to Mutation, Missense

Share to Receptor, ErbB-2

Share to Tandem Repeat Sequences

Source

Open in PubMed Open full text

Identifiers

PMID: 19336545
DOI: 10.1158/1055-9965.EPI-08-1202
PMCID: PMC2730036

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19336545-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heritable variation of ERBB2 and breast cancer risk.PMID 19336545Read ↗

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.Semantic proximity Read ↗

Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.Semantic proximity Read ↗

655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.Semantic proximity Read ↗

ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer.Semantic proximity Read ↗

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.Semantic proximity Read ↗

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.Semantic proximity Read ↗

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.Semantic proximity Read ↗

ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.Semantic proximity Read ↗

Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers.Semantic proximity Read ↗

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.Semantic proximity Read ↗

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.Semantic proximity Read ↗

Germ-line HER-2 variant and breast cancer risk by stage of disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.